A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score

被引：356
|
作者：
Verso, Melina [1 ]
Agnelli, Giancarlo [1 ]
Barni, Sandro [2 ]
Gasparini, Giampietro [3 ]
LaBianca, Roberto [4 ]
机构：
[1] Univ Perugia, Sez Med Interna & Cardiovasc, Stroke Unit, Dipartimento Med Interna, I-06100 Perugia, Italy
[2] Azienda Osped Treviglio Caravaggio, Dept Med Oncol, Treviglio, Italy
[3] San Filippo Neri Hosp, Dept Oncol, Rome, Italy
[4] Osped Riuniti Bergamo, Dept Hematol & Oncol, Med Oncol Unit, I-24100 Bergamo, Italy
来源：
INTERNAL AND EMERGENCY MEDICINE | 2012年 / 7卷 / 03期
关键词：
Gemcitabine; Nadroparin; Predictive Score; High Risk Cancer; Antithrombotic Prophylaxis;
D O I：
10.1007/s11739-012-0784-y
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：291 / 292
页数：2
相关论文
共 50 条
  • [1] A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score
    Melina Verso
    Giancarlo Agnelli
    Sandro Barni
    Giampietro Gasparini
    Roberto LaBianca
    Internal and Emergency Medicine, 2012, 7 : 291 - 292
  • [2] A modified Khorana risk score model for venous thromboembolism in ambulatory cancer patients receiving chemotherapy: the Protecht score
    Verso, M.
    Agnelli, G.
    LaBianca, R.
    Gasparini, G.
    Barni, S.
    Bonizzoni, E.
    Brighenti, M.
    Mandala', M.
    Petrelli, F.
    Bianchini, C.
    Perrone, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 639 - 639
  • [3] Khorana risk score and PROTECHT risk score as prediction models of venous thromboembolism in cancer outpatients receiving chemotherapy: a retrospective analysis
    Barni, S.
    Labianca, R.
    Verso, M.
    Gasparini, G.
    Bonizzoni, E.
    Mandala, M.
    Brighenti, M.
    Petrelli, F.
    Bianchini, C.
    Perrone, T.
    Agnelli, G.
    THROMBOSIS RESEARCH, 2012, 129 : S166 - S166
  • [4] FREQUENCY OF VENOUS THROMBOEMBOLISM AND ITS ASSOCIATION TO KHORANA RISK SCORE IN PATIENTS RECEIVING CHEMOTHERAPY AT GOULBURN VALLEY HEALTH
    Dhar, Patrick
    Torres, Javier
    Tamjid, Babak
    Saqib, Ayesha
    Wong, Zee Wan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 121 - 121
  • [5] Performance of Khorana Risk Score for Prediction of Venous Thromboembolism in Patients With Lung Cancer
    Havlucu, Yavuz
    Kizilirmak, Deniz
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [6] The Khorana score for the prediction of venous thromboembolism in patients with pancreatic cancer
    van Es, N.
    Franke, V. F.
    Middeldorp, S.
    Wilmink, J. W.
    Buller, H. R.
    THROMBOSIS RESEARCH, 2017, 150 : 30 - 32
  • [7] Use of the Khorana score to predict venous thromboembolism in patients undergoing chemotherapy for uterine cancer
    Piver, Rachael N.
    Wagner, Vincent M.
    Levine, Monica D.
    Backes, Floor J.
    Chambers, Laura J.
    Cohn, David E.
    Copeland, Larry J.
    Cosgrove, Casey M.
    Nagel, Christa I.
    'Malley, David M. O.
    Bixel, Kristin L.
    GYNECOLOGIC ONCOLOGY REPORTS, 2023, 46
  • [8] Validation and comparison of the Protecht, Conko, and Khorana score for prediction of venous thromboembolism in ambulatory cancer patients: a retrospective cohort study
    Guman, N. A.
    Mulder, F. I.
    van Es, N.
    Beerepoot, L. V.
    van Laarhoven, H.
    Lolkema, M.
    Buller, H. R.
    THROMBOSIS RESEARCH, 2021, 200 : S65 - S66
  • [9] A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer
    Li, Shuangping
    Gao, Pengfei
    Qiu, Jiayong
    He, Xuegai
    Mao, Yimin
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2021, 52 (03) : 898 - 903
  • [10] Khorana score stratification and incidence of venous thromboembolism among women with ovarian cancer receiving neoadjuvant chemotherapy
    Salinaro, Julia
    Zhang, Yingao
    Buckingham, Lindsey
    Clark, Leslie
    Havrilesky, Laura
    Davidson, Brittany
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S194 - S194
12345